KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Merck Sharp & Dohme B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: d81d0ab3856a5741
Drug Cima Aemps Name: KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1151024002IP1
Holder Company Name: Merck Sharp & Dohme B.V.
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/merck-sharp-and-dohme-bv
Authorization Date: 2021-02-15
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 25 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Merck Sharp & Dohme B.V.
Company Detail Path: /organization/merck-sharp-and-dohme-bv

PEMBROLIZUMAB

100 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 15, 2021

Approval ID

d81d0ab3856a5741

Type

Standard